Academic Unit of Population and Lifespan Sciences, Centre for Perinatal Research, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
Section for Nutrient and Metabolite Sensing, The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2200 Copenhagen, Denmark.
Int J Mol Sci. 2022 Feb 7;23(3):1869. doi: 10.3390/ijms23031869.
Therapeutic activation of thermogenic brown adipose tissue (BAT) may be feasible to prevent, or treat, cardiometabolic disease. However, rodents are commonly housed below thermoneutrality (~20 °C) which can modulate their metabolism and physiology including the hyperactivation of brown (BAT) and beige white adipose tissue. We housed animals at thermoneutrality from weaning to chronically supress BAT, mimic human physiology and explore the efficacy of chronic, mild cold exposure (20 °C) and β3-adrenoreceptor agonism (YM-178) under these conditions. Using metabolic phenotyping and exploratory proteomics we show that transfer from 28 °C to 20 °C drives weight gain and a 125% increase in subcutaneous fat mass, an effect not seen with YM-178 administration, thus suggesting a direct effect of a cool ambient temperature in promoting weight gain and further adiposity in obese rats. Following chronic suppression of BAT, uncoupling protein 1 mRNA was undetectable in the subcutaneous inguinal white adipose tissue (IWAT) in all groups. Using exploratory adipose tissue proteomics, we reveal novel gene ontology terms associated with cold-induced weight gain in BAT and IWAT whilst Reactome pathway analysis highlights the regulation of mitotic (i.e., G2/M transition) and metabolism of amino acids and derivatives pathways. Conversely, YM-178 had minimal metabolic-related effects but modified pathways involved in proteolysis (i.e., eukaryotic translation initiation) and RNA surveillance across both tissues. Taken together these findings are indicative of a novel mechanism whereby animals increase body weight and fat mass following chronic suppression of adaptive thermogenesis from weaning. In addition, treatment with a B3-adrenoreceptor agonist did not improve metabolic health in obese animals raised at thermoneutrality.
治疗性激活产热棕色脂肪组织(BAT)可能有助于预防或治疗心脏代谢疾病。然而,啮齿动物通常被饲养在低于热中性温度(~20°C)下,这会调节它们的代谢和生理机能,包括棕色(BAT)和米色白色脂肪组织的过度激活。我们从断奶开始将动物饲养在热中性温度下,以慢性抑制 BAT,模拟人类生理学,并在这些条件下探索慢性轻度寒冷暴露(20°C)和β3-肾上腺素能受体激动剂(YM-178)的疗效。使用代谢表型和探索性蛋白质组学,我们表明,从 28°C 转移到 20°C 会导致体重增加和皮下脂肪质量增加 125%,而 YM-178 给药则不会产生这种效果,因此表明环境温度较低会直接促进肥胖大鼠的体重增加和进一步肥胖。在 BAT 慢性抑制后,所有组的皮下腹股沟白色脂肪组织(IWAT)中的解偶联蛋白 1 mRNA 均无法检测到。使用探索性脂肪组织蛋白质组学,我们揭示了与冷诱导的 BAT 和 IWAT 体重增加相关的新的基因本体术语,而 Reactome 途径分析则突出了有丝分裂(即 G2/M 过渡)和氨基酸及其衍生物代谢途径的调节。相反,YM-178 对代谢相关途径几乎没有影响,但改变了两种组织中涉及蛋白水解(即真核翻译起始)和 RNA 监测的途径。总之,这些发现表明了一种新的机制,即动物在从断奶开始慢性抑制适应性产热后,体重和脂肪质量增加。此外,在饲养在热中性温度下的肥胖动物中,β3-肾上腺素能受体激动剂的治疗并没有改善其代谢健康。